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espite their importance in cell biology, the mech-
anisms that maintain the nucleus in its proper po-
sition in the cell are not well understood. This is
primarily the result of an incomplete knowledge of the
proteins in the outer nuclear membrane (ONM) that are
able to associate with the different cytoskeletal systems.
Two related ONM proteins, nuclear envelope spectrin
repeat (nesprin)–1 and –2, are known to make direct
connections with the actin cytoskeleton through their
NH
 
2
 
-terminal actin-binding domain (ABD). We have now
isolated a third member of the nesprin family that lacks
D
 
an ABD and instead binds to the plakin family member
plectin, which can associate with the intermediate ﬁla-
ment (IF) system. Overexpression of nesprin-3 results in a
dramatic recruitment of plectin to the nuclear perimeter,
which is where these two molecules are colocalized with
both keratin-6 and -14. Importantly, plectin binds to the
integrin 
 
 
 
6
 
 
 
4 at the cell surface and to nesprin-3 at the
ONM in keratinocytes, suggesting that there is a continu-
ous connection between the nucleus and the extracellular
matrix through the IF cytoskeleton.
 
Introduction
 
The three cytoskeletal filament systems of eukaryotic cells are
composed of actin filaments, intermediate filaments (IFs), and
microtubules (MTs). They are responsible for such diverse
functions as the transport and positioning of organelles in the
cytoplasm, the segregation of the chromosomes during mitosis,
cell shape, cell movement, and the structural integrity of the
membranes (Fuchs and Karakesisoglou, 2001). The three sys-
tems are connected to each other through the members of the
plakin family of cytoskeletal cross-linkers (Sun et al., 2001;
Jefferson et al., 2004). Three members of this family are the
bullous pemphigoid antigen-1 (BPAG1), the MT–actin cross-
linking factor (MACF), and plectin. MACF is primarily re-
sponsible for cross-linking the actin filaments and MTs (Sun et
al., 2001), whereas plectin can directly cross-link the actin and
IF cytoskeletal systems (Wiche, 1998). In BPAG1, there are
several different tissue-specific splice variants that are capable
of cross-linking the actin and MT systems (Leung et al., 2001).
These molecules are very large (834 [BPAG1b], 520 [plectin],
and 608 kD [MACF]) and the binding domains for the different
cytoskeletal systems are on opposite ends of the proteins,
which may allow for a physiologically important spacing be-
tween the different structural systems.
Plakins can also mediate the binding of the cytoskeleton
to membrane-bound protein complexes within a cell (Fuchs
and Karakesisoglou, 2001). The NH
 
2
 
-terminal sequences of the
11 known plectin isoforms, which result from alternative splic-
ing, are important for the cytoplasmic localization of these
molecules (Fuchs et al., 1999; Rezniczek et al., 2003). For ex-
ample, the actin-binding domain (ABD) of plectin-1A and -1C
can bind to the cytoplasmic domain of the integrin 
 
 
 
4 subunit
at the plasma membrane to initiate the formation of hemides-
mosomes, which are adhesion structures that allow for the firm
attachment of the basal epithelial cells to the underlying base-
ment membrane (Borradori and Sonnenberg, 1999; Koster et
al., 2004a). In addition, plectin-1F can become localized at fo-
cal contacts (FCs), whereas plectin-1B is associated with pro-
teins of the mitochondria (Rezniczek et al., 2003). The binding
properties of the latter two isoforms suggest that plectin can
mediate the linkage of the IF system to proteins in lipid bilay-
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ers other than those of the plasma membrane. BPAG1-e (also
known as BP230) also links the IF cytoskeleton to hemidesmo-
somes, and there is evidence that BPAG1 can associate with
transmembrane glycoproteins on the plasma membrane (Guo et
al., 1995; Hopkinson and Jones, 2000; Nakayama et al., 2002;
Koster et al., 2003). MACF, on the other hand, has been re-
ported to be localized at the plasma membrane at cell–cell con-
tacts and, recently, to membranes of the Golgi apparatus (Kar-
akesisoglou et al., 2000; Kakinuma et al., 2004; Lin et al.,
2005). Together, the evidence shows that the plakin family
members, in addition to their role as cross-linkers of the cy-
toskeleton, can form a bridge between membrane-bound pro-
teins and the various cytoskeletal systems. However, no plakin
family members have been reported to associate with proteins
of the nuclear envelope (NE).
The NE separates the nucleoplasm from the cytoplasm
and consists of two lipid bilayers, the inner nuclear membrane
(INM) and the outer nuclear membrane (ONM). The INM
contains a distinctive set of integral membrane proteins that
interact with chromatin through associated proteins such as the
nuclear lamins, which is a meshwork of IF proteins that under-
lies the INM (Burke and Stewart, 2002). Lamins themselves
can also bind chromatin and play an essential role in maintain-
ing the structural integrity of the NE (Hutchison, 2002; Gruen-
baum et al., 2005). The proper position of the nucleus in a cell
is thought to be maintained through the linkage of ONM pro-
teins to the different cytoskeletal systems. In vertebrates, the
only ONM proteins known to make associations with the cy-
toskeleton are the related integral membrane proteins NE spec-
trin repeat
 
 
 
(nesprin)–1 and –2, which bind to actin through
their NH
 
2
 
-terminal ABDs (Zhang et al., 2002). However, in
 
Caenorhabditis elegans
 
, UNC-83 can link the nucleus to the
MT cytoskeleton (Starr et al., 2001). This suggests that in
higher organisms there are ONM proteins that can link the nu-
cleus not only to the actin cytoskeleton but also to MTs.
The type II ONM proteins nesprin-1 and -2 (also known
as Myne-1 and -2; Mislow et al., 2002), Syne-1 and -2 (Apel et
al., 2000), or Enaptin and Nuance (Zhen et al., 2002; Padmaku-
mar et al., 2004) contain a central rod domain with a variable
number of spectrin repeats (SRs), flanked by an NH
 
2
 
-terminal
ABD and a conserved COOH-terminal domain (Zhang et al.,
2001, 2002). The NH
 
2
 
-terminal ABD is of the type found in
 
 
 
-spectrin and consists of two calponin homology domains.
The conserved COOH-terminal domain, which includes the
transmembrane domain (TM) and the COOH-terminal amino
acids present in the periplasmic space of the NE, shares a ho-
mologous region with the 
 
Drosophila melanogaster
 
 protein
Klarsicht and is therefore referred to as the Klarsicht/ANC-1/
Syne-1 homology (KASH) or Klarsicht-like domain. However,
apart from this domain there are no other features shared with
the 
 
D. melanogaster 
 
protein (Mosley-Bishop et al., 1999). In
humans, both nesprin-1 and -2 are giant proteins with molecu-
lar masses of 
 
 
 
976 and 764 kD, respectively. Because of the
presence of an ABD, it has been suggested that nesprins play
an important role in nuclear positioning. Indeed, the single ho-
mologue of nesprin in 
 
C. elegans
 
, ANC-1, is required for the
proper anchorage of nuclei to actin in syncytial cells (Starr and
Han, 2002, 2003) and recently, overexpression of the KASH
domain in mice highlighted the importance of Syne-1 for the
proper positioning and localization of synaptic nuclei (Grady
et al., 2005).
We have identified a new member of the nesprin family
that can bind to the plakin family member plectin at the ONM.
This protein was isolated in a yeast two-hybrid (Y2H) screen
using the ABD of plectin-1C as bait. Like the other two known
nesprins, nesprin-3 is a type II transmembrane protein of the
ONM and contains a COOH-terminal KASH domain and a se-
ries of SRs related to those in nesprin-1 and -2. Unlike the other
two full-length nesprins, nesprin-3 lacks an ABD and is there-
fore not able to associate with actin, but instead may associate
with the IF cytoskeleton through plectin. Nesprin-3 is ubiqui-
tously expressed in all cell lines and tissues tested. Expression
of nesprin-3 strongly recruited endogenous plectin to the ONM
in cells, where it was colocalized with both keratin-6 and -14
filaments. Nesprin-3 is the first ONM protein with an estab-
lished link to the IF cytoskeletal system, and it seems certain
that its discovery will increase our knowledge of the function
of the NE during mitosis and proper nuclear positioning during
quiescence and cell migration.
 
Results
 
Identification of a novel protein that 
interacts with the plectin ABD
 
It is well documented that the integrin 
 
 
 
4 subunit is bound to
plectin in hemidesmosomes (Borradori and Sonnenberg, 1999).
We have shown previously that the critical binding site be-
tween plectin and 
 
 
 
4 occurs through the first pair of fibronectin
type III (FNIII) domains of 
 
 
 
4 and the NH
 
2
 
-terminal ABD of
plectin (Geerts et al., 1999; Litjens et al., 2003; Koster et al.,
2004b). We were curious to find out if additional proteins
could bind to the plectin ABD. For this purpose, we performed
a Y2H genetic screen using the human plectin-1C ABD as bait.
We identified several novel interactions with both known and
previously unidentified proteins. Of the unknown proteins, one
showed homology with the related type II ONM proteins, ne-
sprin-1 and -2. We then tested the ability of the nesprin-related
Figure 1. Y2H analysis of the interaction between either the nesprin-
related Y2H sequence or the first pair of FNIII domains of  4 with several
different ABDs. Interactions were scored   when the plating efficiencies
on selective SC-LTHA plates were  30% of those on nonselective SC-LT
plates at 5 d of growth. Interactions were scored   when no colonies
were detected at 10 d of growth. The percent homology of the other ABDs
to the plectin ABD is shown in the column on the left. The results for the in-
teractions of the first pair of FNIII domains with the ABDs listed have been
reported previously (Litjens et al., 2003). 
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protein sequence to bind to other ABDs in a Y2H assay, using
the previously published results for the first pair of FNIII do-
mains of 
 
 
 
4 to bind the same ABDs as a control (Litjens et al.,
2003). The results show that, like 
 
 
 
4, the nesprin-related se-
quence binds to the plectin-1C ABD and the BPAG1-n ABD,
which is highly homologous to the plectin ABD (76% homol-
ogy). However, the nesprin-related protein sequence, also like
 
 
 
4, did not bind to the ABDs of dystrophin, 
 
 
 
-actinin-1, and
filamin-A and -B (Fig. 1). We conclude that the nesprin-related
sequence has the same binding specificity as the 
 
 
 
4 subunit for
the different ABDs.
 
Genomic organization of nesprin-3
 
A basic local alignment search tool search with the novel plec-
tin-1C ABD binding sequence showed stretches of nucleotide
sequences identical with an Institute of Physical and Chemical
Research (RIKEN) complementary DNA (cDNA; 4831426I19)
and homology to a region in nesprin-1 and -2 containing a vari-
able number of SRs. In the mouse genome, the nesprin-1 gene
is on chromosome 10A1 (human homologue 6q25) and the ne-
sprin-2 gene is on chromosome 12C3 (human homologue
14q23.2). Software analysis revealed that the gene for the
novel nesprin-related sequence is also on chromosome 12,
but in a different location than nesprin-2, in region 12E (hu-
man homologue 14q32.13, showing 72% homology). Database
searches revealed that the cDNA for the nesprin-related protein
sequence is also present in cDNA libraries of several other spe-
cies, including the rat, chimpanzee, dog, and chicken (68,
68, 50, and 43% homology, respectively). Furthermore, the
RIKEN clone contained a COOH-terminal KASH domain that
was similar to that found in nesprin-1 and -2 (51 and 61% pro-
tein sequence homology, respectively; Fig. 2 A). These data-
base analyses indicate that the nesprin-related cDNA sequence
encodes a novel nesprin family member, which will be referred
to as nesprin-3.
Comparison of the RIKEN cDNA 4831426I19 and the
nesprin-3 Y2H nucleotide sequences with the mouse genomic
sequence on chromosome 12 revealed that these two ORFs rep-
resent splice variants of the nesprin-3 gene because we identi-
fied alternatively spliced exon 1 sequences for the Y2H and
RIKEN sequences, labeled exons 1a and 1b, respectively, and
an additional 173-nucleotide exon in the Y2H sequence (exon 3;
Fig. 2 B and Fig. S1, A and B, available at http://www.jcb.org/
cgi/content/full/jcb.200506083/DC1). Additionally, both se-
quences contain an identical exon 2, but the reading frame
is different in this exon for the two nesprin-3 splice vari-
ants; therefore, these proteins have different NH
 
2
 
-terminal se-
quences (Fig. S1 A). RT-PCR analysis on total mRNA from
several cell lines suggests that after exon 3 the nucleotide (and
protein) sequence is the same in the two splice variants and is
Figure 2. Sequence analysis of nesprin-3. (A) Scaled dia-
grams of the nesprin-1, -2, -3 , and -3 , ANC-1, UNC-83,
and D. melanogaster Klarsicht protein are presented. The
sequence alignment of the KASH domain of the different
murine nesprins, ANC-1 and UNC-83, with the conserved
domain in the D. melanogaster Klarsicht protein is shown
with similar amino acids shaded gray. (B) Organization of
the nesprin-3 genome. The 18 exons are labeled as E1–
E18 and are depicted as closed bars, except the exon
unique to nesprin-3  (E3), which is depicted as an open
box. The translation start sites for nesprin-3  and -3  are
shown in E2. The distances are drawn to scale with the
measurement bar. (C) SRs 1, 3, 5, and 7, and 2, 4, 6,
and 8 of nesprin-3  are shown aligned with the 13th and
14th SRs of spectrin- 2, respectively. Dark gray boxes de-
pict alignment of more than three similar amino acids in an
alignment set. Light gray boxes depict similar amino acids
to a majority of those in the opposing alignment set. A dia-
mond indicates that residues are conserved in only one
alignment set, and an asterisk indicates residues that are
conserved in both sets. Below the SR alignment the struc-
tures of nesprin-3  and -3  are shown. The location of the
exons are denoted by bars and labeled in between each
accordingly as E1–E18. The region of nesprin-3  encoded
by the cDNA found in the Y2H screen is underlined, as is
the sequence for nesprin-3  (RIKEN clone 4831426I19)
found in the database. The SRs are depicted as open
boxes. In exon 18, the RIKEN sequence continues for an-
other 2,198 nucleotides after the stop codon. The NH2 ter-
minus is to the left and the COOH terminus is to the right.
The distances are drawn to scale. 
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encoded by exons 4–18 (Fig. 2 B, Fig. 3 C, and Fig. S1 A).
Because the nesprin-3 Y2H sequence was the originally dis-
covered sequence and may represent a longer nesprin-3 variant,
we will now refer to this variant as nesprin-3
 
 
 
, whereas the
RIKEN cDNA–encoded polypeptide will be referred to as
nesprin-3
 
 
 
.
Using the simple modular architecture research tool
(SMART) motif scanning software, we identified several SRs
in nesprin-3. The protein sequence showed 25% homology
with the same region in both mouse and human nesprin-1 and
22% homology with the same region in human nesprin-2.
Manual inspection of the nesprin-3
 
 
 
 cDNA sequence showed
the presence of eight related SRs, some of which were not rec-
ognized by the SMART software (Fig. 2 C and Fig. S1 A). The
first SR is encoded by the nesprin-3
 
 
 
 alternative reading frame
in exon 2 and the nesprin-3
 
 
 
–specific exon 3. Therefore, ne-
sprin-3
 
 
 
 does not have the first SR, but does contain SRs 2–8
(Fig. 2 C and Fig. S1 A).
To determine if longer variants of nesprin-3 exist, we per-
formed 5
 
 
 
–rapid analysis of cDNA ends (RACE) analysis on
mRNA from the Rac-11P and mTSC cell lines. The results in-
dicate that the original nesprin-3 Y2H sequence contains the
true start site of translation for nesprin-3
 
 
 
 because the longest
transcript detected containing exon 1a did not have any me-
thionines that are in-frame with the nesprin-3
 
 
 
 Y2H polypep-
tide (Fig. S1 A). Although exon 1a was the most frequently
detected first exon in both cell lines, we did identify multiple
other exon 1 splice variants of nesprin-3 (exons 1c, 1c
 
 
 
, 1d, 1e,
and 1f; Fig. S1 B). Three of the alternative exon 1 sequences,
exons 1c
 
 
 
, 1d, and 1e, contain upstream in-frame stop codons
that preclude the possibility of any additional start sites for
translation, but two exon 1 sequences, exons 1c and 1f, contain
other potential start sites of translation that would encode for
an additional 38 and 30 amino acids upstream of the initiation
methionine of nesprin-3
 
 
 
, respectively (Fig. S1 B). Longer
nesprin-3 variants in the nesprin-3
 
 
 
 reading frame are not
Figure 3. Tissue and cell line distribution of nesprin-3. (A) The indicated mouse-derived cell lines were lysed with RIPA buffer to extract NE components.
Whole cell lysates (WCLs) of untransfected, nesprin-3  cDNA–transfected, or nesprin-3  cDNA–transfected COS7 cells were included as controls. WCL
samples were loaded and run in a 4–20% SDS-PAGE gel, transferred to PVDF membrane, and probed for the presence of nesprin-3 using the GST-nesprin-3-
SR7–derived antibodies. A protein blot for  -actin was used as a loading control. (B) The indicated mouse tissues were dounce homogenized in RIPA
buffer. WCLs of these samples were analyzed as in B. A protein blot for  -tubulin was used as a loading control. (C) To determine the selectivity of nesprin-
3  and -3  expression, the mouse cell lines NMK-1, mTSC, and mBCC-1 were used. Primers annealing on either side of the nesprin-3 –specific exon 3
(primers 1 and 2) were used to determine the presence of either variant in these cell lines (top; see Results). Primers that would amplify exons 15–18 of ne-
sprin-3 (primers 3 and 4) were used as a control for mRNA fidelity and specificity (middle). Nesprin-3  and -3  cDNAs were used as controls in these PCR
reactions. A PCR of GAPDH was also included as a control for nesprin-3 expression levels and mRNA fidelity (bottom). Schematic representations (Fig. 2 C)
of the regions of nesprin-3  and -3  amplified by primer pairs are shown underneath the image. Only part of nesprin-3 is depicted, for simplicity. 
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possible because of a stop codon in exon 2 just upstream of the
starting methionine (Fig. S1 A). The results of the 5
 
 
 
-RACE
analysis suggest that transcript variants equivalent to the long
isoforms of nesprin-1 and -2 do not exist of nesprin-3.
 
Distribution of nesprin-3 in cell lines and 
tissues
 
To further characterize the nesprin-3 protein, rabbit polyclonal
antibodies (pAbs) were generated against the seventh SR of
murine nesprin-3 and, subsequently, the pAbs were tested for
their specificity to nesprin-3 (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200506083/DC1). We first
tested the expression of nesprin-3 in 14 different mouse-derived
cell lines. A band of 
 
 
 
110 kD, corresponding to nesprin-3
 
 
 
,
was detected in all 14 cell lines tested, suggesting that this vari-
ant of nesprin-3 is ubiquitously expressed (Fig. 3 A). We did
not detect any higher molecular mass bands in any of these cell
lines, which is consistent with the notion that we are dealing
with the full-length nesprin-3 protein.
We next tested the expression of nesprin-3 in several dif-
ferent mouse tissues and in all of these tissues we detected the
110-kD protein (Fig. 3 B). A 97-kD protein reacting with the
nesprin-3 antibody is likely a degradation product of the ne-
sprin-3
 
 
 
 protein because this band is also present in the lysates
of the vesicular stomatitis virus (VSV)-nesprin-3
 
 
 
–transfected
COS7 cells. These results indicate that nesprin-3 is ubiqui-
tously expressed in tissues and most likely represents the larg-
est and most widely expressed splice variant of nesprin-3.
To verify this at the mRNA level, we used an RT-PCR–
based method to detect the presence of either nesprin-3
 
 
 
 or -3
 
 
 
in three different cell lines. We used primers that anneal in
exon 2 and 4, thus encompassing the nesprin-3
 
 
 
–specific exon 3.
A PCR band of 228 bp represents nesprin-3
 
 
 
 and a band of 401
bp represents nesprin-3
 
 
 
 because of the inclusion of the 173 bp
of exon 3. We also performed a control RT-PCR reaction that
would amplify a region of nesprin-3 from exon 15–18, which
includes the KASH domain–encoding sequence (Fig. 3 C). For
both primer pairs, PCRs of the nesprin-3
 
 
 
 and -3
 
 
 
 cDNA–con-
taining plasmids were included as controls (Fig. 3 C). The re-
sults showed that in three different mouse-derived cell lines,
NMK-1, mTSC, and mBCC-1, the predominant nesprin-3
splice variant was 3
 
 
 
, although its expression level differed
(Fig. 3 C). This is consistent with the results obtained from the
Western blots of the same mouse cell lines (Fig. 3 A).
 
Nesprin-3 is localized at the ONM
 
To determine the subcellular location of nesprin-3, we tran-
siently transfected pyloric atresia associated with junctional
epidermolysis bullosa
 
 
 
(PA-JEB) keratinocytes with constructs
expressing GFP- or VSV-tagged nesprin-3
 
 
 
 and -3
 
 
 
 proteins.
The results indicate that GFP-nesprin-3
 
 
 
 and -3
 
 
 
 are localized
at the NE, although there is some staining within the nucleus,
which is likely caused by the folding of the NE. The location of
nesprin-3 was confirmed by colocalization studies with endog-
enous lamin A, which is a structural protein known to reside at
the nucleoplasmic side of the INM (Fig. 4 A). Immunofluores-
cence studies of the VSV-tagged nesprin-3
 
 
 
 and -3
 
 
 
 proteins
and endogenous nesprin-3 also showed localization at the NE
and, in some cells, at the RER (Fig. 5 B and not depicted). To-
gether, these results definitively show that nesprin-3 is a NE
component. The results also indicate that the GFP and VSV
tags do not affect the localization of the nesprin-3 proteins.
Because confocal microscopy is not sensitive enough to deter-
mine which lipid bilayer of the NE contains nesprin-3, we used
EM analysis on PA-JEB cells stably expressing either GFP-
nesprin-3
 
 
 
 or -3
 
 
 
. Using antibodies directed against the GFP
moiety, we were able to show that, like nesprin-1 and -2, ne-
sprin-3 is also present in the ONM (Fig. 4 B; Starr and Han,
2002; Zhen et al., 2002). Furthermore, some cells showed
strong staining of nesprin-3 in the RER (Fig. 4 B), which was
always correlated with a higher level of nesprin-3 expression in
individual cells (Fig. 5 B).
 
Nesprin-3
 
 
 
 is associated with plectin at 
the ONM
 
To verify the results of the Y2H assay, we coexpressed cDNAs
of VSV-nesprin-3
 
 
 
 and -3
 
 
 
, along with cDNAs encoding
either a HA-tagged plectin-1A or -1C ABD, a HA-tagged
MACF ABD, which has an ABD similar to that of plectin
Figure 4. Subcellular localization of nesprin-3  and -3 . (A) To determine
the subcellular location of nesprin-3, PA-JEB keratinocytes were transiently
transfected with either GFP-nesprin-3  or -3  cDNA, and the expression
pattern was analyzed by fluorescence microscopy. Immunofluorescence
studies of endogenous lamin A were performed using mAb 133A2. Bar,
20  M. Four cells are shown in each image. (B) To determine which lipid
bilayer of the NE contains nesprin-3, ultrathin sections of PA-JEB cells stably
expressing either nesprin-3  (top and middle) or -3  (bottom) were la-
beled with rabbit pAbs against GFP, followed by incubation with 15-nm
gold-conjugated protein A. NPC, nuclear pore complex.JCB • VOLUME 171 • NUMBER 5 • 2005 804
(76% homology), or a HA-tagged  -actinin-1 ABD in COS7
cells. To test the ability of the nesprin-3 proteins to bind to the
different ABDs, immunoprecipitations were prepared with anti-
HA antibodies and tested for the presence of the different ne-
sprin-3 splice variants. Consistent with the findings shown in
Fig. 1, the results of the pull-down assay show that nesprin-3 
strongly interacts with the ABDs of plectin-1A and -1C, but not
with that of  -actinin-1. Interestingly, nesprin-3  can also inter-
act with the MACF ABD (Fig. 5 A). Unexpectedly, nesprin-3 
only weakly interacted with any of the ABDs tested. This result
suggests that the first SR is critical for the high affinity binding
of nesprin-3  to the plectin and MACF ABDs and we have
therefore named this region of nesprin-3  the plakin-binding do-
main. These results were later confirmed by using a cDNA of ne-
sprin-3  of which the upstream, noncoding sequences that were
present in the original Y2H clone had been removed, verifying
the importance of the SR1 in mediating binding to the plectin
and MACF ABDs (Fig. S1 A and not depicted).
The results thus far indicate that nesprin-3  can directly
associate with plectin at the ONM. To verify these results, we
used immunofluorescence studies on these proteins in cells.
We first looked at the location of endogenous nesprin-3 and
plectin in mouse embryonic fibroblast (MEF) cells. The results
show that nesprin-3 is indeed present at the NE, but that plectin
is not obviously concentrated at the nuclear perimeter, although
it is present throughout the cytoplasm (Fig. 5 B). One possible
reason for the relatively low concentration of plectin at the NE
may be the ability of the actin cytoskeleton to bind and se-
quester plectin (Wiche, 1998), thereby limiting the amount of
plectin available for interacting with nesprin-3 . To test this
notion, we stably overexpressed GFP-nesprin-3  or -3  into
PA-JEB or PA-JEB/ 4 cells and performed colocalization
studies with plectin. We hypothesized that nesprin-3 , but not
nesprin-3 , when overexpressed, competes with actin for bind-
ing to plectin, resulting in the sequestration of plectin at the
NE. To determine whether plectin, when bound to nesprin-3 ,
can also associate with IFs, we also labeled cells with antibod-
ies that recognize keratin-6 and -14. The results show that ne-
sprin-3  can strongly recruit plectin to the ONM in both the
PA-JEB and PA-JEB/ 4 cells and, consistent with the findings
shown in Fig. 5 A, nesprin-3  did not recruit plectin to the NE.
The keratin-6 and -14 IF proteins are also strongly stained at
the nuclear perimeter, which infers that plectin may mediate
the association of the IFs to nesprin-3  at the NE (Fig. 5 C).
Figure 5. Nesprin-3  associates with plectin in cells.
(A) COS7 cells were transiently transfected with either the
nesprin-3  (lanes 1–5) or -3  (lanes 6–10) cDNA con-
structs, or a control plasmid (lanes 10–15) and expres-
sion constructs for the HA-plectin-1A ABD (lanes 1, 6,
and 11), HA-plectin-1C ABD (lanes 2, 7, and 12), HA-
MACF ABD (lanes 3, 8, and 13), HA- -actinin-1 ABD
(lanes 4, 9, and 14), or a control plasmid (lanes 5, 10,
and 15). The cells were lysed in RIPA buffer and HA-IPs
were probed for the presence of nesprin-3 (top) and the
HA-tagged ABDs (middle). WCLs were probed for expres-
sion levels of the two different nesprin-3 isoforms (bottom).
(B) MEF cells were stained for endogenous plectin using
the mAb 121 (A) and nesprin-3 using rabbit pAbs (D).
The location of the nucleus was visualized using Topro
staining (B and E). C is a composite of A and B, and F is
a composite of D and E. Bar, 20  M. (C) PA-JEB (A–T) or
PA-JEB/ 4 (U–X) were stably transduced with retroviral
constructs expressing either GFP-nesprin-3  (A–D, I–L,
and Q–X) or GFP-nesprin-3  (E–H and M–P). Fluores-
cence studies were done to locate the GFP moiety (A, E,
I, M, Q, and U), along with immunofluorescence studies
of endogenous plectin (B, F, J, N, R, and V) and keratin-6
(C and G) or keratin-14 (K, O, S, and W). The far right
image of each row depicts the composite image of the
first three images in each row (D, H, L, P, T, and X). Four
cells are shown in each image except for images Q–T,
which show a higher magnification of the nucleus. All
images are maximum projections. Bars: (A–P and U–X)
20  M; (Q–T) 10  M. (D) To determine the subcellular
localization of nesprin-3 and plectin at the NE, ultrathin
sections of PA-JEB cells stably expressing nesprin-3  were
labeled with rabbit pAbs against the plectin-ABD (D16),
followed by incubation with 10-nm gold-conjugated pro-
tein A. The sections were then fixed in 1% glutaraldehyde
and reprobed with rabbit pAbs against GFP, followed
by incubation with 15-nm gold-conjugated protein A.
Arrows indicate areas where plectin and GFP-nesprin-3 
are colocalized at the ONM (bottom). Control labeling
was done in the same way, except that after plectin label-
ing and fixation in glutaraldehyde, the sections were
reprobed with 15-nm gold-conjugated protein A only (top). Note that no labeling with 15-nm gold was seen at the NE. (E) PA-JEB/ 4 cells stably expressing
either GFP-nesprin-3  (A–F) or GFP-nesprin-3  (G–I) were visualized for GFP (A, D, and G) and plectin (B, E, and H). The far right image of each row
depicts the composite image of the first two images in each row (C, F, and I). All images are maximum projections. Bar, 20  M.NESPRIN-3 ASSOCIATES WITH PLECTIN • WILHELMSEN ET AL. 805
In addition, a higher magnification of the nucleus showed al-
most equally strong staining of nesprin-3 , plectin, and kera-
tin-6 at the ONM (Fig. 5 C). We also performed EM studies to
determine the exact location of plectin and GFP-nesprin-3  in
PA-JEB cells. The results confirm that nesprin-3  and plectin
are situated together at the ONM (Fig. 5 D). These findings
clearly demonstrate that nesprin-3  can bind plectin at the
ONM in cells. Intriguingly, the results also suggest that plectin
may mediate the linkage of nesprin-3  with the keratin-6/16
and -5/14 IF systems.
We also decided to make use of a GFP-nesprin-3  con-
struct, which lacks the KASH domain but contains the sequence
present in the original Y2H clone (GFP-nesprin-3 
 KASH; Fig.
2 C). This clone retains the sequences necessary to bind plectin,
but because of the absence of the KASH domain it is not local-
ized at the ONM and instead displays a filamentous cyto-
plasmic and nuclear distribution (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200506083/DC1). We stained
for plectin along with either keratin-5 or F-actin in PA-JEB
cells transiently expressing GFP-nesprin-3 
 KASH to determine
whether it had any effect on the distribution of these proteins.
GFP-nesprin-3 
 KASH did not significantly alter the distribution
of plectin and was only partially colocalized with plectin in the
cytoplasm of the PA-JEB cells (Fig. S3). However, the GFP-
nesprin-3 
 KASH proteins were specifically localized along the
keratin-5 IFs and they did not become localized with the actin
cytoskeleton (Fig. S3). Because nesprin-3  binds to the ABD
of plectin, the plakin repeats are free to make associations with
the IF cytoskeleton, which can partially account for the local-
ization of GFP-nesprin-3 
 KASH along IFs and, similarly, GFP-
nesprin-3 
 KASH will compete with actin for binding to the
plectin ABD, which is why it was not present along actin fila-
ments. The observed imaging of GFP-nesprin-3 
 KASH along IFs
in the absence of plectin staining may be a result of other plec-
tin isoforms that are present in PA-JEB cells that are not recog-
nized by the mAb 121 against plectin (i.e., the rod-less variant;
Fig. S3). Additionally, the filamentous patterning of GFP-nesprin-
3 
 KASH in the absence of keratin-5 staining is most likely caused
by the association of these proteins with other IF networks
(Fig. S3). Together, the nesprin-3  proteins lacking the KASH
domain do not obviously affect the IF network or the distribution
of plectin, but they do provide additional evidence that plectin
links nesprin-3  to the IF cytoskeleton.
The integrin  6 4 and nesprin-3  both 
associate with plectin in keratinocytes
Our findings suggest the possibility that in basal keratinocytes
plectin links the IFs to nesprin-3  at the ONM and to integrin
 6 4 at hemidesmosomes at the plasma membrane. This
would allow for a continuous protein scaffolding from the ex-
tracellular environment to the nucleus. We decided to take a
closer look at PA-JEB/ 4 cells that stably express either GFP-
nesprin-3  or GFP-nesprin-3 . In most PA-JEB/ 4 cells ex-
pressing GFP-nesprin-3 , we saw staining of plectin at the NE
and the presence of plectin in hemidesmosomes (Fig. 5 C).
However, in some PA-JEB/ 4 cells expressing GFP-nesprin-
3 , there was almost no staining of plectin at the NE, which co-
incided with a strong expression of plectin in hemidesmo-
somes, or alternatively, in some cells there was strong staining
of plectin at the NE with almost no hemidesmosomal staining
(Fig. 5 E). This effect was never seen in PA-JEB/ 4 cells ex-
pressing GFP-nesprin-3 , which consistently showed hemides-
mosomal staining of plectin (Fig. 5 E). These results suggest
that  4 and nesprin-3  compete for binding to the same pool of
plectin and, moreover, that plectin may link these two proteins
to the same IF cytoskeleton.
Endogenous nesprin-3 and plectin 
associate in cells
To verify that endogenous nesprin-3  and plectin can associate
at the ONM in cells, we used small interfering RNA (siRNA)
knock-down of nesprin-3 in the mouse Sertoli cell line TM-4.
We selected these cells because it has previously been reported
that there is a high concentration of plectin around their nuclear
perimeter (Guttman et al., 1999), and therefore any effects on
plectin redistribution will be more easily detected. As ex-
pected, nesprin-3 is expressed in TM-4 cells (Fig. S4 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200506083/
DC1). We then designed a siRNA construct in a region of the
mouse nesprin-3 cDNA that was present in both splice variants
and tested its efficacy by coexpressing cDNAs of VSV-
nesprin-3  and -3 , along with cDNAs encoding either the ne-
sprin-3 siRNA, a luciferase control siRNA, or an empty vector
control plasmid in human-derived 293 human embryonic kidney
cells. The results show that the nesprin-3 siRNA specifically
knocks down the expression of transiently expressed nesprin-3 
and -3  proteins (Fig. S4 B).
We next wanted to verify that the nesprin-3 siRNA can
knock-down the expression of the protein in TM-4 cells and to
determine the location of plectin in these cells. The nesprin-3
siRNA– or luciferase control siRNA–containing vectors were
independently transfected into TM-4 cells, along with a mono-
meric red fluorescent protein (mRFP) expression plasmid, and
the cells were stained for endogenous plectin and nesprin-3
(Fig. 6 A). The mRFP protein was visualized to determine
whether the cells express the siRNAs. The results show that the
nesprin-3 siRNA can specifically knock-down the expression
of the protein at the NE in TM-4 cells. The results also show
that the knock-down of nesprin-3 does not obviously affect the
distribution of plectin, but do show that in some cells plectin is
concentrated around the NE as reported previously (Guttman et
al., 1999). Interestingly, in fully spread cells plectin is primar-
ily present in FCs and colocalized with F-actin (Fig. 6 B). Like
that from MEF cells, the data obtained from TM-4 cells sug-
gests that nesprin-3  and actin filaments compete for binding
to plectin. Therefore, we decided to disrupt the actin network in
TM-4 cells using latrunculin B. This should have resulted in an
increased amount of plectin available to interact with nesprin-
3  at the ONM and, indeed, this is what was observed (Fig. 6 B).
To determine if the recruitment of plectin to the nuclear perim-
eter is dependent on the presence of nesprin-3 , we expressed
the nesprin-3 siRNA–containing vector in TM-4 cells and
treated the cells with latrunculin B. The concentration of plec-
tin around the nuclear perimeter in these cells was significantlyJCB • VOLUME 171 • NUMBER 5 • 2005 806
reduced, with plectin now being distributed in the cytoplasm
(Fig. 6 B), which suggests that the recruitment of plectin to the
ONM after actin depolymerization is indeed dependent on ne-
sprin-3 . These data also infer that the plectin that is concen-
trated around the nuclear perimeter in cells that were not fully
spread is also dependent on an association with nesprin-3 .
Together, the data presented thus far clearly demonstrate that
nesprin-3  can bind plectin at the ONM in cells.
Nesprin-3  does not associate with 
MACF at the ONM
The results shown in Fig. 5 A infer that nesprin-3  may also
bind MACF at the ONM, which intriguingly suggests that ne-
sprin-3  may connect the nucleus to MTs (Jefferson et al.,
2004). We again used the PA-JEB cells, which stably overex-
press the GFP-nesprin-3  or -3  proteins, but instead stained
them for the presence of endogenous MACF and MTs. The re-
sults show that nesprin-3  cannot recruit MACF to the nuclear
perimeter even though MTs were present at the NE (Fig. S5 A,
available at http://www.jcb.org/cgi/content/full/jcb.200506083/
DC1), suggesting that MACF and nesprin-3  do not associate in
cells. It is possible, however, that the strong association between
plectin and GFP-nesprin-3  in the PA-JEB cells may prevent
binding of MACF to nesprin-3  and, thus, its recruitment to the
ONM. To investigate this possibility, we stably expressed either
the GFP-nesprin-3  or -3  proteins in epidermolysis bullosa
simplex with muscular dystrophy  (EBS-MD) keratinocytes
(Geerts et al., 1999), whose cells do not express full-length
plectin and express the rodless variant of plectin at relatively
low levels (Koster et al., 2004b). Therefore, if there is compe-
tition between plectin and MACF for binding to nesprin-3 , it
will be minimal and the recruitment of MACF to nesprin-3  at
the ONM should therefore be increased. The results from the im-
munofluoresence experiments show that there is an increase of
MACF staining around the nuclear perimeter as compared with
that in the PA-JEB cells. However, this does not appear to de-
pend on the expression of nesprin-3  (Fig. S5 B). Together,
these data suggest that, unlike plectin, MACF does not bind to
nesprin-3  in cells and that the interaction between plectin and
nesprin-3  at the ONM is specific.
Discussion
We have identified nesprin-3 as a novel member of the nesprin
family of ONM proteins. One splice variant, nesprin-3 , is able
to bind to the plakin family member plectin at the NE. In kerat-
inocytes, nesprin-3  and the integrin  4 subunit both bind to
plectin, which also binds to the keratin IF system, suggesting
that hemidesmosomes at the cell surface may be connected di-
rectly to the nucleus via the same cytoskeletal systems. In con-
trast, nesprin-3  cannot associate with endogenous MACF in
cells, even though the MACF ABD binds to nesprin-3  in
coimmunoprecipitation experiments, suggesting that, in cells,
the interaction between the plectin ABD and nesprin-3  is spe-
cific. We have also identified a minor splice variant, nesprin-
3 , which is unable to bind or recruit plectin to the ONM.
Nesprin-1 and -2 are gigantic molecules of  976 and 764
kD, respectively. However, several smaller variants of nesprin-1
and -2, which are produced by alternative RNA splicing and/
or initiation sites of transcription, have been identified that lack
the NH2-terminal ABD. The structure of nesprin-3 closely re-
sembles that of nesprin-1  and -2 , which suggested to us that
nesprin-3  and -3  are most likely smaller splice variants of a
larger nesprin-3 molecule. However, several lines of evidence
show that this is not the case. First, we could not identify cDNAs
in either the mouse or the human databases containing se-
quences in exons upstream of the alternatively spliced exon 1,
and careful analysis of upstream genomic sequences failed to
identify sequences present in a calponin homology motif.
Second, 5 -RACE-PCR on mRNA from different cell lines
failed to identify any longer transcripts containing exons up-
stream of those for nesprin-3 , as indicated in Fig. 1. Finally,
our nesprin-3 pAbs failed to detect any larger nesprin-3 vari-
ants in any of the cell lines or tissues we tested. Based on these
data, it appears that nesprin-3  is the largest variant of this new
nesprin family member.
Figure 6. Endogenous nesprin-3 and plectin associate in TM-4 cells.
(A) The mouse Sertoli cell line TM-4 was transiently transfected with either
the pSUPER vector expressing the nesprin-3 siRNA (A–D) or the luciferase
siRNA (E–H), along with an expression vector for mRFP at a 5:1 ratio. After
72 h, the cells were fixed and stained for endogenous plectin (A and E) and
nesprin-3 using our pAbs (C and G). mRFP was visualized to determine
which cells express the siRNAs (B and F). D and H are composite images of
the first three images in each row. All images are maximum projections.
Bar, 20  M. (B) TM-4 cells were left untransfected (A–H) or transiently trans-
fected with the pSUPER vector expressing the nesprin-3 siRNA, along with
an expression vector for mRFP in a 5:1 ratio (I–L). After 72 h and just before
fixation, the cells in images E–L were treated for 30 min with 0.2  M latrun-
culin B. The cells were then fixed and stained for plectin (B, F, and J),
nesprin-3 (C, G, and K), and F-actin (A and E). mRFP was visualized to
determine which cells express the nesprin-3 siRNA (I). D, H, and L are
composite images of the first three images in each row. Bar, 10  M.NESPRIN-3 ASSOCIATES WITH PLECTIN • WILHELMSEN ET AL. 807
The results from our immunofluorescence studies using
either full-length nesprin-3  or a nesprin-3  protein lacking the
KASH domain provide strong, although circumstantial, evi-
dence that plectin can mediate the linkage of the IF cytoskeleton
to nesprin-3  at the ONM. This is especially relevant because
the IF interaction site and the ABD are on opposite ends of the
plectin molecule ( 500 kD), therefore it seems unlikely that the
binding of plectin to the IF cytoskeleton would interfere with its
binding to nesprin-3 . Thus, it is reasonable to conclude that
nesprin-3  can indeed link the nucleus to the IF cytoskeleton
through plectin. In nesprin-1/2, the KASH domain is located at
the COOH-terminus, whereas the ABD is located at the NH2-
terminus at a distance of  150–200 nm (Starr and Han, 2003).
This suggests that there must be a relatively large space be-
tween the ONM and the actin cytoskeleton. It became apparent
to us that a similar space may be important between the ONM
and the IFs because, like nesprin-1/2, plectin is extremely large
and when it is bound to nesprin-3 , a comparable distance is
achieved. At present, it is not clear why such a space is required
between the ONM and the different cytoskeletal systems. It has
also been reported that some isoforms of nesprin-1/2 are lo-
calized at the INM (Zhang et al., 2001; Libotte et al., 2005).
However, we found no concrete evidence that nesprin-3 is so
localized. It therefore appears that the nesprin family of pro-
teins have evolved to link the nucleus to the various cytoskeletal
systems, either directly (i.e., nesprin-1/2) or indirectly via mem-
bers of the plakin family (i.e., nesprin-3). However, we detected
only subtle, inconsistent effects on the IF cytoskeleton when ne-
sprin-3  was overexpressed or when nesprin-3 was knocked-
down by siRNAs. Moreover, our data with the TM-4 cells sug-
gests that plectin may only be associated with nesprin-3  at the
ONM during specific cellular events because we consistently
saw that plectin was more concentrated around the nucleus
when the TM-4 cells were more contracted or when the actin
cytoskeleton was disrupted, whereas there is very little plectin
around the nucleus in fully spread cells containing well defined
actin stress fibers. It is possible that the function of nesprin-3 
is to sequester plectin during such processes as cell division or
migration when the cells contract and become more rounded
because of cytoskeletal rearrangements.
We have also identified a splice variant of nesprin-3 that
is unable to associate with plectin. The original nesprin-3 
RIKEN clone 4831426I19 is derived from head tissue of a day
0 neonatal mouse. Consistent with the origin of the RIKEN
clone, we observed a faint protein band corresponding to the
molecular mass of nesprin-3  in a lysate derived from brain
tissue. However, nesprin-3  is not ubiquitously or strongly
expressed in cells because we did not detect it by Western
blotting or RT-PCR analysis in several different cell lines and
tissues. The existence of this splice variant suggests that nesprin-3
must have functions other than connecting the nucleus to the
IFs or sequestering plectin.
The results of our Y2H and pull-down assays show that
nesprin-3  and the  4 subunit have the same binding specificity
for the different ABDs. We found this surprising because the
plectin ABD binding region on the first pair of FNIII domains
of  4 (i.e.,   sheets; de Pereda et al., 1999) is structurally very
different from the SRs in nesprin-3  (i.e.,  -helices; Yan et al.,
1993). In fact, our original Y2H screen with the plectin-1C
ABD also identified a novel interaction with an SR-rich region
of  2-spectrin, suggesting that the binding of an ABD to SRs is
not unique for nesprin-3 (unpublished data). It has been shown
previously that the binding of the plectin ABD to the  4 FNIII
domains and to actin is mutually exclusive (Geerts et al., 1999).
Because of the similarities in binding specificity, we believe
that this is also true for the binding of the plectin ABD to ne-
sprin-3  and actin, although competition studies will have to
prove this. If confirmed, this would suggest that in a cell the re-
cruitment of plectin to actin filaments and to nesprin-3  is com-
petitive, which could partially explain why we saw minimal
staining of plectin at the nuclear perimeter in cells with well-
defined actin stress fibers, but saw recruitment of plectin to the
ONM when nesprin-3  was overexpressed or when the actin
cytoskeleton was disrupted. Our results also show that nesprin-
3  can bind the ABDs of MACF and BPAG1-n. These two pro-
teins would allow nesprin-3  to also link the nucleus to MTs.
However, we could not confirm an interaction between full-
length MACF and nesprin-3  in PA-JEB or EBS-MD kerati-
nocytes, suggesting that the endogenous proteins do not associ-
ate or that the binding between the MACF ABD and nesprin-3 
is regulated differently in these cells.
Our finding that in keratinocytes nesprin-3  can compete
with the integrin  4 subunit for binding to plectin suggests that
these two molecules are connected to the same IF system.
Indeed, immunofluorescence studies showed that the keratin-14
IF system is colocalized with both plectin at the NE and plectin
in hemidesmosomes (Geerts et al., 1999). This implies that plec-
tin can be the link in a continuous protein scaffold from the extra-
cellular matrix to the nucleus via the IF cytoskeleton (Fig. 7),
Figure 7. Model depicting how the nesprins can link the nucleus to the
actin and IF cytoskeletal systems. Nesprin-3 at the ONM and the integrin
 4 subunit at the cell surface are shown bound to the NH2-terminal plectin
ABD. COOH-terminal plectin plakin repeats are free to make associations
with IFs, thus linking the nucleus to the hemidesmosomes at the cell surface.
In an analogous way, nesprin-1/2 and talin, bound to the cytoplasmic tail
of   integrins, interact with the actin filaments, which link the nucleus to
FCs (black, IF cytoskeleton; green, MT system; red, F-actin). MTOC, MT
organizing center.JCB • VOLUME 171 • NUMBER 5 • 2005 808
analogous to the manner in which nesprin-1/2 can link the nu-
cleus to FCs at the plasma membrane via actin filaments (Fig. 7).
This notion is consistent with the cellular tensegrity model,
which describes the cell as a prestressed structure whereby forces
can be transferred from the extracellular environment through the
different cytoskeletons into the nucleus (Ingber, 2003a,b). This
model integrates and explains many observations in cell biol-
ogy, such as nuclear architecture, but importantly it can explain
how external forces may affect events in the nucleus such as
chromatin organization (Maniotis et al., 1997). The nesprins
are the prime candidates for mediating these processes because
they have been shown to interact with INM proteins associated
with the nuclear lamins (Gruenbaum et al., 2005). The lamins
are known to bind chromatin and have even been suggested to
play a role in regulating transcription by RNA polymerase II
and DNA replication (Spann et al., 1997, 2002). If force can in-
deed directly alter gene expression, the need for cytoplasmic
signaling events would be circumvented, allowing for a more
instantaneous regulation of transcriptional events during cell
migration or situations of applied force. Although these ideas
are intriguing, clearly more studies are necessary to determine
the extent to which the nesprins can mediate the transfer of
force into the nucleus.
Materials and methods
Y2H assay
A Y2H screen with a mouse embryonic day 17 cDNA library (CLONTECH
Laboratories, Inc.) cloned into the yeast Gal4 transcriptional activation do-
main (AD) expression vector pGAD10 (CLONTECH Laboratories, Inc.) was
performed. The cDNA sequence of the human plectin-1C ABD, which was
fused in-frame to the Gal4 DNA-binding domain (BD) of the pAS2.1 vector
(CLONTECH Laboratories, Inc.), was used as bait (Geerts et al., 1999). Plas-
mids were introduced into the yeast strain PJ69-4A (a gift from P. James, Uni-
versity of Wisconsin, Madison, WI) by transformation, as described in the
CLONTECH two-hybrid manual. Protein–protein interactions between bait
and prey were confirmed by cotransformation into PJ69-4A, as described
previously (Schaapveld et al., 1998; Geerts et al., 1999). Expression of the
fusion proteins in yeast was confirmed by immunoblotting with Gal4(BD)-
and Gal4(AD)-specific antibodies (Santa Cruz Biotechnology, Inc.).
Cell lines, antibodies, and other reagents
COS7 and MEF cells were grown in DME (Life Technologies) containing
10% fetal calf serum, 100 U/ml penicillin, and 100 U/ml streptomycin.
COS7 cells were transiently transfected with cDNA constructs using the
DEAE-dextran method (Seed and Aruffo, 1987), and MEF cells were trans-
fected with Effectene (QIAGEN). The PA-JEB and EBS-MD keratinocyte cell
lines were maintained in keratinocyte serum-free medium (Life Technolo-
gies) supplemented with 50  g/ml bovine pituitary extract, 5 ng/ml EGF,
100 U/ml penicillin, and 100 U/ml streptomycin. The mouse Sertoli cell
line TM-4 was maintained in DME containing 2.5% fetal calf serum, 5%
horse serum, 15 mM Hepes, pH 7.4, 100 U/ml penicillin, and 100 U/ml
streptomycin. The following mouse-derived cell lines were also used:
Tam2D2-lymphoma; N115-neuroblastoma; GE11-epithelial; C2C12-myo-
blast; J774-macrophage; NMK-1-keratinocyte; mTSC-tumor stem cell;
mBCC-1-basal cell carcinoma; and RAC-11P and mSCC-1, -2, -3, -4-squa-
mous cell carcinoma. Stable integration of the  4 integrin and GFP-
nesprin-3 /  were performed as described previously (Sterk et al., 2000).
Murine nesprin-3 rabbit pAbs were raised against the seventh SR (Fig. S1
A) common to both 3  and 3  and fused to GST (see cDNA constructs for
specifics). This antigen sequence shows 93% (rat), 67% (dog), 64% (hu-
man), 63% (chimpanzee), and 43% (chicken) homology to the same re-
gion of nesprin-3 in other species. This sequence also shows 34% homol-
ogy to nesprin-1 (mouse) and 23% homology to spectrin- 2 (mouse), and
is therefore not likely to cross react. The lamin A mAb (133A2) was a gift
from F. Ramaekers (University of Maastricht, Maastricht, Netherlands).
The mouse mAb 121 against plectin/HD1 was provided by K. Owaribe
(University of Nagoya, Nagoya, Japan; Hieda et al., 1992). The mono-
clonal  4 antibody (450-11A) was purchased from BD Biosciences. The
monoclonal tubulin antibody was obtained from Sigma-Aldrich. The poly-
clonal MACF antibody CU119 was a gift from R. Liem (Columbia Univer-
sity, New York, NY) and has been described previously (Lin et al., 2005).
The polyclonal GFP antibody was made at Sanquin Blood Supply Founda-
tion and has been described previously (van Ham et al., 1997). The affin-
ity column–purified plectin ABD rabbit pAb (D16) was made as described
previously (Geerts et al., 1999). Keratin-5, -6 (PRB-169P), and -14 (AF64)
rabbit pAbs were purchased from Covance Research Products, Inc. The
HA mAb (12CA5) and polyclonal HA antibody (Y-11) were purchased
from Santa Cruz Biotechnology, Inc.; the donkey anti–rabbit and goat
anti–mouse horseradish peroxidase–conjugated antibodies were pur-
chased from GE Healthcare; the goat anti–mouse FITC-conjugated anti-
serum was obtained from Rockland Immunochemicals, Inc.; and the goat
anti–rabbit Texas red–conjugated antibodies were purchased from Invitro-
gen. Phalloidin-Texas red and latrunculin B were purchased from Sigma-
Aldrich and TOP-RO was obtained from Invitrogen.
cDNA constructs
pcDNA3-VSV was generated by inserting a 100-bp fragment, containing
two VSV tags (YTDIEMNRLGK) flanked by KpnI, ClaI, and NcoI sites up-
stream and a BamHI site downstream, into the KpnI–BamHI sites of
pcDNA3 (Invitrogen). 
Nesprin-3.  PCR fragments of nesprin-3  (clone 4831426I19;
RIKEN) were cloned into the BamHI–EcoRV sites of the pcDNA3-VSV vec-
tor in two steps. First, the COOH-terminal part containing the sequence
starting from the internal BamHI site (exon 10) until the end was cloned,
and, second, the NH2-terminal part until the internal BamHI site was in-
serted. The published sequence for the clone contains a single cytosine
nucleotide insertion just after position 2,652. The original nesprin-3 
construct was made by inserting the NH2-terminal fragment (containing
the upstream, noncoding sequences present in the Y2H clone [Fig. S1 A])
until the internal BamHI site into a pcDNA3-VSV vector that already con-
tained the COOH-terminal part of nesprin-3 . A nesprin-3  construct was
also made that had the upstream, noncoding sequences removed. This
was done by inserting a PCR fragment that was generated from a primer
annealing to the internal BamHI site and a primer containing an upstream
BamHI site fused to sequences annealing to nucleotides that encode for
the first six amino acids of nesprin-3  (Fig. S1 A) into the original nesprin-
3  pcDNA3-VSV vector using BamHI–BamHI sites. Nesprin-3  was
cloned into pEGFP-C3 (CLONTECH Laboratories, Inc.) using HindIII–EcoRI
sites. Subsequently, nesprin-3  in pLZRS-IRES-zeo was obtained by first in-
serting GFP into the BamHI–EcoRI sites of this vector with subsequent inser-
tion of the EcoRI digest of nesprin-3  from pEGFP-C3. Nesprin-3  was
cloned into pEGFP-C3 using HindIII–SalI sites. The NheI–SalI sites of this
construct were used to obtain the GFP-nesprin-3  fragment for cloning into
the SwaI–XhoI sites of pLZRS-IRES-zeo. The NheI site was blunt ended using
T4 polymerase. The nesprin-3  lacking the KASH domain (GFP-nesprin-
3 
 KASH) construct was made by amplifying the region of the nesprin-3  se-
quence identified in the original Y2H plasmid (Fig. S1 A) with primers con-
taining BamHI and XbaI restriction sites, and this PCR fragment was then
subsequently cloned into the pcDNA3-VSV vector. The insert was then cut
out of pcDNA3-VSV with HindIII and XbaI and the XbaI site was then blunt
ended. The pEGFP-C3 vector (CLONTECH Laboratories, Inc.) was cut with
HindIII and EcoRI and the EcoRI site was blunt ended. The insert was then
cloned into this vector. 
HA-tagged ABDs.  The HA-tagged plectin constructs have been de-
scribed previously (Litjens et al., 2003). The sequence for the BPAG1-n
(dystonin-1) ABD (amino acids 1–388) in pcDNA3-HA was generated by
PCR using BamHI–NotI restriction sites. The MACF ABD cDNA sequence
(amino acids 1–327) in pcDNA3-HA was generated by digestion out of a
construct provided by R. Liem using EcoRI–BamHI restriction sites. The
 -actinin-1 ABD cDNA (amino acids 1–337) in pcDNA3-HA was gener-
ated by PCR using EcoRI–NotI restriction sites. Both the  -actinin-1 and
BPAG1-n ABD cDNAs in pAS2-1 on which the PCRs were performed have
been described previously (Litjens et al., 2003). The GST-nesprin-3-SR7
antigen was made by cloning the nesprin-3 SR7–derived PCR product (us-
ing primers 5 -cgcggggaattcccaccttcagtcacaggctg-3  and 5 -ggccgcgcg-
gccgctctcatgagactcagcat-3 ) into pGEX-4T-2 (GE Healthcare) digested
with EcoRI and NotI. GST preparations were done as previously described
(Wilhelmsen et al., 2002) and fusion proteins were eluted from glu-
tathione-Sepharose beads using 15 mM of reduced glutathione. All PCR
fragments were generated using the proofreading Pwo DNA polymerase
(Roche). All plasmids were verified by sequencing, and protein expression
and size were confirmed by Western blotting.NESPRIN-3 ASSOCIATES WITH PLECTIN • WILHELMSEN ET AL. 809
Coimmunoprecipitation experiments
Cells were grown to confluency on 10-cm tissue culture dishes, rinsed
twice with cold TBS, and lysed in 1 ml of 10 mM Na-phosphate, pH 7.0,
150 mM NaCl, 1% NP-40, 1% DOC, 0.1% SDS, 2 mM EDTA, 50 mM
NaF, 100  M sodium vanadate, 10  g/ml aprotinin, and 10  g/ml leu-
peptin (radioimmunoprecipitation [RIPA]-lysis buffer) per 10-cm tissue cul-
ture dish. Lysates were cleared by centrifugation at 10,000 rpm in a mi-
crofuge at 4 C for 45 min. Nesprin-3 proteins were immunoprecipitated
by incubation of cell lysates with 100  l of a 10% slurry of polyclonal
anti–Nesprin-3-SR7 antiserum coupled to protein A–Sepharose beads with
dimethyl pimelimidate dihydrochloride (Sigma-Aldrich) with rocking for 1 h
at 4 C. Immunoprecipitates were washed four times with 1 ml RIPA-lysis
buffer, boiled for 5 min in 62.5 mM Tris/Cl, pH 6.8, 10% glycerol, 5%
 -mercaptoethanol, 5 mM DTT, 2.3% SDS, and 0.025% Bromophenol blue
(SDS–sample buffer) and resolved by SDS-PAGE. For anti-HA immunopre-
cipitates, cell lysates were incubated by rocking for 1 h at 4 C with 100
 l of a 10% slurry of anti-HA mAb prebound to  -bind–Sepharose (GE
Healthcare) in the presence of 1% BSA.
Immunofluorescence
PA-JEB, EBS-MD, and MEF cells were grown on glass coverslips, fixed
with either 1 or 3% paraformaldehyde in PBS for 10 min, and permeabi-
lized with 0.5% Triton X-100 in PBS for 5 min at room temperature. The
TM-4 cells were fixed and permeabilized with 1% paraformaldehyde
containing 0.5% Tween 20 in PBS for 10 min. After washing in PBS and
blocking with 2% BSA in PBS for 60 min at room temperature, the cells
were incubated with primary antibodies for 45 min at room temperature
and then washed three times with PBS. Cells were then incubated with
either FITC, Cy5, or Texas red–labeled secondary antibodies for 45 min
at room temperature. Coverslips were washed three times in PBS,
mounted in Mowiol/DAPCO, and viewed under a confocal scanning la-
ser microscope (model SP-2 AOBS; Leica) at room temperature. Images
were visualized with either a PL APO 40 , 1.25 NA, or a PL APO (CS)
63  1.4 NA objective lens (Leica) using LCS software and captured
with a photomultiplier.
EM slides
EM was done as previously described (Sterk et al., 2000), with the follow-
ing modifications. Ultrathin sections of cells were fixed in 2% paraformal-
dehyde and were either labeled with rabbit pAbs against the plectin-ABD
(D16), followed by incubation with 10-nm gold-conjugated protein A, or
labeled with rabbit pAbs against GFP, followed by incubation with 15-nm
gold-conjugated protein A.
Nesprin-3 siRNA
The mouse nesprin-3 sequence (5 -gctacgtagaatcatcaca-3 ) and luciferase
sequence used for siRNA knock-down studies was cloned into the pSUPER
vector (Brummelkamp et al., 2002). The vectors were transfected into TM-4
cells using the effectene protocol (QIAGEN) and 293 human embryonic
kidney cells using the lipofectamine protocol (Invitrogen). The cells were
lysed with RIPA buffer or fixed 72 h after transfection and assayed for
nesprin-3 expression.
Exon detection primers
In Fig. 3 C, the primers annealing to either side of the nesprin-3 –specific
exon 3 were 5 -gagcggccctggaggcaaggcttc-3  (primer 1) and 5 -caggag-
cacagcctgattgtccac-3  (primer 2), and the primers amplifying exons 15–18
of nesprin-3 were 5 -gaacagtggctgcaggcag-3  (primer 3) and 5 -
ggtgggcggggggccattgtaccg-3  (primer 4). We also used primers anneal-
ing in exon 4 (5 -cgcatcgagtgggtgtggctgcac-3 ) and exon 10 (5 -gtccttgt-
gctgaacaagcaggct-3 ) to determine if other potential downstream splice
variants exist.
RACE-PCR
5 -RACE-PCR to determine the 5 -sequences of nesprin-3 was performed
using the second generation 5 /3  RACE-PCR (Roche) according to the
manufacturer’s specifications. Antisense primers annealing to the 5  end
of the known nesprin-3 sequence used in the RACE reactions were 5 -cag-
gagcacagcctgattgtccac-3 , 5 -cacgttgtgcagcagcacctg-3 , and 5 -atcctc-
cacgctcctctc-3 .
Database mining (websites)
Information pertaining to this study is available at the following websites:
ELM (www.elm.eu.org), ClustalW (www.ebi.ac.uk/clustalw), SMART
(smart.embl-heidelberg.de), basic local alignment search tool (www.ncbi.
nih.gov/BLAST), mouse genome research (www.ncbi.nih.gov/genome/
guide/mouse), and human genome research (www.ncbi.nlm.nih.gov/
genome/guide/human).
Online supplemental material
Fig. S1 A shows the organization of the nesprin-3  cDNA, whereas Fig.
S1 B lists all the alternative exon 1 sequences that were detected for ne-
sprin-3 by 5 -RACE-PCR. In Fig. S2, the specificity of the nesprin-3 pAb
that was generated against the seventh SR is demonstrated. Fig. S3 is a
confocal microscopy image showing that the nesprin-3 proteins lacking
the KASH domain are localized along keratin-5 IFs and not along F-actin.
Fig. S4 A biochemically confirms that TM-4 cells express nesprin-3 and
Fig. S4 B demonstrates the knock-down specificity of the siRNAs that were
designed against nesprin-3. Finally, the data in Fig. S5 B indicates that ne-
sprin-3  cannot associate with full-length MACF in keratinocytes. Online
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200506083/DC1.
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